David Reynolds Founder of LoQus23 Therapeutics Backed byNovartis Venture FundArgeris Karabelas LinkedIn SourcesLoQus23 Therapeutics raises £35m to fight Huntington’s disease — 2024-10 Browse all founders · Browse investors